Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | REGN5093 |
Trade Name | |
Synonyms | REGN-5093|REGN 5093|davutamig |
Drug Descriptions |
REGN5093 is a bispecific MET antibody that targets two different epitopes on MET, potentially leading to degradation of MET and decreased tumor cell growth (PMID: 37059804, NCI Drug Dictionary). |
DrugClasses | MET Antibody 31 |
CAS Registry Number | 2648058-48-2 |
NCIT ID | C167188 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
REGN5093 | REGN5093 | 0 | 1 |